<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01778205</url>
  </required_header>
  <id_info>
    <org_study_id>IISPV_Murphy1</org_study_id>
    <secondary_id>SPAIN MICINN</secondary_id>
    <secondary_id>SPAIN ISCIII</secondary_id>
    <secondary_id>SPAIN URV</secondary_id>
    <secondary_id>SPAIN ISCIII</secondary_id>
    <secondary_id>SPAIN ISCIII</secondary_id>
    <secondary_id>SPAIN AEI</secondary_id>
    <secondary_id>Horizon 2020</secondary_id>
    <nct_id>NCT01778205</nct_id>
  </id_info>
  <brief_title>The Reus-Tarragona Birth Cohort Study of Early Development and Ageing.</brief_title>
  <official_title>Phase 1 Study of the Effect of Maternal Nutritional Status on Placental Vascular Function, Fetal Growth and Intrauterine Growth Retardation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Investigacio Sanitaria Pere Virgili</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Italfarmaco</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Agencia Estatal de Investigación, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>JPI ERA-HDHL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitat Rovira i Virgili</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Regional Development Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Investigacio Sanitaria Pere Virgili</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The recent fall in birth and death rates has led to demographic changes such as low fertility&#xD;
      and high life expectancy . The WHO reports the median age of the European population to be&#xD;
      the highest in the world and predicts that the proportion of over-60s in will increase from&#xD;
      14% in 2010 to 25% in 2050. There is wide variability in the quality of health and well-being&#xD;
      in the ageing population. Longevity with a good quality of life is a consequence of the&#xD;
      combination of an individual's genes, nutrition, environment, lifestyle and medical&#xD;
      interventions. There is increasing evidence that research into healthy ageing needs to start&#xD;
      with early life data to capture all traits and exposures experienced by an individual&#xD;
      throughout life. Epigenetic imprinting occurs both in utero and during early postnatal&#xD;
      development. Maternal environmental exposures, including nutritional status, may have a&#xD;
      permanent effect on the developing foetus by influencing epigenetic profiles and leading to&#xD;
      life-long genome adaptation. Numerous reports show that restricted intra-uterine growth due&#xD;
      to poor maternal nutrition during pregnancy increases risk in the offspring of developing&#xD;
      mental disorders, metabolic syndrome, cardiovascular disease or stroke in later life. To&#xD;
      understand the basic mechanisms and interactions through which the ageing phenotype develops,&#xD;
      systems involved in key processes of early development must be considered as well as those&#xD;
      crucial to health in older persons. The Reus and Tarragona Birth Cohort is a longitudinal&#xD;
      study. In the first phase, blood is collected from pregnant women at &lt;12, 15, 24-27 and 34&#xD;
      gestational weeks (GW) and at labor and from the cord. Detailed lifestyle, habits and&#xD;
      supplement use data are collected at 20 and 32 gestational weeks and on nutritional habits at&#xD;
      &lt;12GW and at birth. Placental vascular function is assessed at 20 and 32 GW by analysis of&#xD;
      Doppler waveforms of the uterine arteries. Data on pregnancy evolution and outcome are also&#xD;
      recorded. The first phase investigates the association between gene-environment (nutrient and&#xD;
      lifestyle habits) interactions and fetal growth and pregnancy outcome. The second phase of&#xD;
      the study follows up the children at 7.5 years of age. Growth, exercise and nutritional&#xD;
      habits as well as environment and cognitive development are assessed. The aims are to&#xD;
      investigate the association between gene-environment interactions associated with healthy&#xD;
      development from early pregnancy until 7.5 years of age.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">September 14, 2020</completion_date>
  <primary_completion_date type="Actual">September 14, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Birth weight</measure>
    <time_frame>At birth</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Doppler waveforms of uterine arteries</measure>
    <time_frame>20 gestational weeks</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>1-C metabolites</measure>
    <time_frame>&lt;12, 15, 24-27, 34 gestational weeks, at labor, in the cord</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Intrauterine growth retardation</measure>
    <time_frame>At birth</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">831</enrollment>
  <condition>Intrauterine Development</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <description>Pregnant women with confirmed viable fetus at first prenatal check-up at &lt;12 gestational weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <arm_group_label>Pregnant women</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma Serum Leukocytes Placenta&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women less than 12 weeks pregnant at their first pre-natal check up are recruited from the&#xD;
        URV University Hospitals: Sant Joan (Reus) and Joan XXIII (Tarragona)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &lt;12 weeks pregnant at first prenatal check up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Illnesses / interventions affecting nutritional status, major recent surgery in the&#xD;
             previous 6 months, multiple pregnancies&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle M Murphy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitat Rovira i Virgili</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pere Cavallé-Busquets, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitari Sant Joan de Reus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joan D Fernandez-Ballart, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitat Rovira i Virgili</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mónica Ballesteros, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital de Tarragona Joan XXIII</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitari Sant Joan de Reus</name>
      <address>
        <city>Reus</city>
        <state>Tarragona</state>
        <zip>43201</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Tarragona Joan XXIII</name>
      <address>
        <city>Tarragona</city>
        <zip>43005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Colomina JM, Cavallé-Busquets P, Fernàndez-Roig S, Solé-Navais P, Fernandez-Ballart JD, Ballesteros M, Ueland PM, Meyer K, Murphy MM. Maternal Folate Status and the BHMT c.716G&gt;A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy. Nutrients. 2016 Oct 9;8(10). pii: E621.</citation>
    <PMID>27735840</PMID>
  </reference>
  <reference>
    <citation>Solé-Navais P, Salat-Batlle J, Cavallé-Busquets P, Fernandez-Ballart J, Ueland PM, Ballesteros M, Ornosa-Martín G, Inglès-Puig M, Colomina JM, Murphy MM. Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy. Am J Clin Nutr. 2018 Feb 1;107(2):173-182. doi: 10.1093/ajcn/nqx041.</citation>
    <PMID>29529156</PMID>
  </reference>
  <reference>
    <citation>Roigé-Castellví J, Murphy M, Hernández-Martínez C, Solé-Navais P, Cavallé-Busquets P, Fernández-Ballart J, Ballesteros M, Canals J. The effect of prenatal smoke exposure on child neuropsychological function: a prospective mother-child cohort study. J Reprod Infant Psychol. 2020 Feb;38(1):25-37. doi: 10.1080/02646838.2019.1580350. Epub 2019 Feb 19.</citation>
    <PMID>30777448</PMID>
  </reference>
  <reference>
    <citation>Cavallé-Busquets P, Inglès-Puig M, Fernandez-Ballart JD, Haro-Barceló J, Rojas-Gómez A, Ramos-Rodriguez C, Ballesteros M, Meyer K, Ueland PM, Murphy MM. Moderately elevated first trimester fasting plasma total homocysteine is associated with increased probability of miscarriage. The Reus-Tarragona Birth Cohort Study. Biochimie. 2020 Jun;173:62-67. doi: 10.1016/j.biochi.2020.01.008. Epub 2020 Jan 18.</citation>
    <PMID>31962182</PMID>
  </reference>
  <results_reference>
    <citation>Fernàndez-Roig S, Cavallé-Busquets P, Fernandez-Ballart JD, Ballesteros M, Berrocal-Zaragoza MI, Salat-Batlle J, Ueland PM, Murphy MM. Low folate status enhances pregnancy changes in plasma betaine and dimethylglycine concentrations and the association between betaine and homocysteine. Am J Clin Nutr. 2013 Jun;97(6):1252-9. doi: 10.3945/ajcn.112.054189. Epub 2013 Apr 17.</citation>
    <PMID>23595875</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 25, 2013</study_first_submitted>
  <study_first_submitted_qc>January 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut Investigacio Sanitaria Pere Virgili</investigator_affiliation>
    <investigator_full_name>Dr. Michelle Murphy</investigator_full_name>
    <investigator_title>Profesora agregat</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

